Kenya advances local manufacturing of health products and technologies

Kenya has launched a five-year local manufacturing strategy (2026–2030) to expand domestic production of medicines, vaccines, diagnostics and medical devices, targeting 70% utilisation of existing capacity and WHO regulatory benchmark achievement. The country currently imports 70–80% of pharmaceuticals consumed despite being Africa's third-largest pharmaceutical exporter, and the strategy aims to close that gap through capacity utilisation, Good Manufacturing Practice certification, and multi-year public procurement commitments.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.